Hemophilia
📧 Sign up to get email alerts when something new happens for Hemophilia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-07-16Clinical Trial Update: Characterization of Laboratory Response to DDAVP in Adult Hemophilia A Carriers [Phase 1]
This Phase 1 study update characterizes how adult Hemophilia A carriers respond in the laboratory to desmopressin (DDAVP).
-
CLINICAL_TRIALS trial_result · 2018-06-20Clinical Trial Update: 2-cohort Study of Adult Patients With Severe Hemophilia A in Greece
A completed clinical trial update on a two-cohort study in adults with severe Hemophilia A conducted in Greece, sponsored by Bayer.
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: Comparing the Burden of Illness of Hemophilia in the Developing and the Developed World
This completed clinical trial compares the burden of illness of hemophilia A and B between developing and developed countries, highlighting …
-
FDA approval · 2018-05-14FDA Approved: TRANEXAMIC ACID — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for tranexamic acid from Mylan Institutional LLC, granting approval for the generic product.
-
CLINICAL_TRIALS trial_result · 2018-05-14Clinical Trial Update: Phase 3 Efficacy and Safety Study of BAX 855 in Severe Hemophilia A Patients Undergoing Surgical Procedures [Phase 3]
A Phase 3 study of BAX 855 in severe Hemophilia A patients undergoing surgical procedures has completed with results posted in 2018.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-04-25Clinical Trial Update: Virtual Reality for Hemophilia [NA]
A clinical trial evaluating the use of virtual reality for individuals with Hemophilia A or Hemophilia B has completed. No efficacy or detai…
-
CLINICAL_TRIALS research · 2018-04-19Clinical Trial Update: Hemophilia Mobile App Usability Pilot [NA]
A usability pilot is reported for a mobile application intended for people with hemophilia; no study results or current status details are p…
-
CLINICAL_TRIALS trial_result · 2018-04-06Clinical Trial Update: Pharmacokinetics and Safety of rFVIIIFc Manufactured at 15,000 L (15K) Scale [Phase 3]
Phase 3 study assessing pharmacokinetics and safety of rFVIIIFc produced at 15,000 L scale for severe hemophilia A.
-
CLINICAL_TRIALS trial_result · 2018-04-05Clinical Trial Update: Genetic Susceptibility to Factor VIII Inhibitors
This update notes the completion of a clinical trial investigating genetic factors that influence susceptibility to developing Factor VIII i…
-
CLINICAL_TRIALS trial_result · 2018-03-29Clinical Trial Update: Risk Models to Optimise Prophylaxis Schedules in Children With Haemophilia
This update reports on a completed clinical trial evaluating risk models to optimize prophylaxis schedules for children with hemophilia.
-
CLINICAL_TRIALS other · 2018-03-29Clinical Trial Update: An Expanded Access Program of Emicizumab in Participants With Hemophilia A With Inhibitors
Expanded access program update for emicizumab in participants with Hemophilia A with inhibitors, outlining current program status and access…
-
CLINICAL_TRIALS trial_result · 2017-12-04Clinical Trial Update: DDAVP vs. Exercise in Patients With Mild Hemophilia A [Phase 4]
A Phase 4 clinical trial update comparing desmopressin (DDAVP) to exercise in patients with mild Hemophilia A without inhibitors.
-
CLINICAL_TRIALS research · 2017-12-04Clinical Trial Update: Health Practice of Hemophilia Patiente Care During Pregnancy, Delivery and Newborn Children
A completed clinical study evaluating health care practices for managing hemophilia in pregnancy, delivery, and newborn care.
-
CLINICAL_TRIALS trial_result · 2017-11-24Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants With Inhibitors [Phase 3]
Phase 3 trial evaluating emicizumab prophylaxis versus no prophylaxis in people with Hemophilia A and inhibitors; study completed and result…
-
CLINICAL_TRIALS trial_result · 2017-10-31Clinical Trial Update: World Bleeding Disorders Registry Pilot Study
This update reports the completion of the World Bleeding Disorders Registry Pilot Study, a World Federation of Hemophilia–sponsored registry…
-
CLINICAL_TRIALS trial_result · 2017-10-03Clinical Trial Update: Study of Biostate for Treatment of Children With Hemophilia A Complicated by Antibody Development [Phase 3]
Phase 3 trial of Biostate for treatment of children with Hemophilia A and antibody development was terminated.
-
EMA research · 2017-09-15Factor VIII medicines: no clear and consistent evidence of difference in risk of inhibitor development between classes
A European Medicines Agency assessment concludes there is no clear or consistent evidence that different classes of Factor VIII medicines di…
-
CLINICAL_TRIALS trial_result · 2017-08-24Clinical Trial Update: Study of Biostate® in Children With Hemophilia A [Phase 3]
Phase 3 trial of Biostate in children with Hemophilia A has completed.
-
FDA approval · 2017-08-22FDA Approved: DESMOPRESSIN ACETATE — Original Application (Sagent Pharmaceuticals)
FDA approved the Original Application for Desmopressin Acetate (DESMOPRESSIN ACETATE) by Sagent Pharmaceuticals, providing a generic version…
-
FDA approval · 2017-08-22FDA Approved: DESMOPRESSIN ACETATE — Original Application (Sagent Pharmaceuticals)
FDA approved an original application for Desmopressin Acetate from Sagent Pharmaceuticals, establishing a generic version of the product.
-
CLINICAL_TRIALS trial_result · 2017-07-28Clinical Trial Update: Safety and Efficacy of NNC-0156-0000-0009 in Haemophilia B Patients [Phase 3]
A Phase 3 trial evaluating the safety and efficacy of NNC-0156-0000-0009 in Hemophilia B completed, with results posted on July 28, 2017.
-
CLINICAL_TRIALS trial_result · 2017-07-25Clinical Trial Update: Efficacy and Safety of AlphaNine Versus BeneFIX in Patients With Severe Hereditary Haemophilia B [Phase 2]
Phase 2 trial comparing AlphaNine with BeneFIX in patients with severe hereditary Hemophilia B to assess efficacy and safety; results have b…
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Phase III Study of Coagulation FVIIa (Recombinant) in Congenital Hemophilia A or B Patients With Inhibitors [Phase 3]
Phase 3 study of recombinant coagulation factor VIIa in congenital hemophilia A or B patients with inhibitors; results were posted in 2017.
-
CLINICAL_TRIALS research · 2017-05-30Clinical Trial Update: A Prospective Study to Collect High-Quality Documentation of Bleeds, Health-Related Quality of Life (HRQoL), and Safety Outcomes in Patients With Hemophilia A Treated With Standard-of-Care Treatment
This prospective study completed data collection on bleeds, health-related quality of life, and safety outcomes in patients with Hemophilia …
-
FDA approval · 2017-05-26FDA Approved: DESMOPRESSIN ACETATE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved an Original Application for Desmopressin Acetate as a generic product manufactured by Heritage Pharmaceuticals Inc. d/b/a Avet …